Reading Room

FHI's Quarterly Health Bulletin Network

Experimental Male Contraceptives

Network: Spring 1998, Vol. 18, No. 3

NetworkCopyright Family Health International, 1998. 
Network is reprinted with permission from Family Health International
.

Contraceptive prototypes for men use one of two mechanisms of action: some suppress sperm production, either through hormonal or non-hormonal means; others inhibit the ability of sperm to fertilize the ovum, usually by disrupting a key step necessary for conception.
Agent How it Works Research Status
Hormonal Suppression of Sperm Production
Gonadotropin hormone- releasing hormone (GnRH) coupled with protein
  • Stimulates immune system to inactivate the body's natural GnRH, suppressing sperm production
  • Annual injection
Two-year safety trial of gonadotropin hormone-releasing hormone (GnRH) combined with tetanus toxoid protein recently begun in 20 men.
7-alpha methyl-19-nortestosterone (MENT)
  • Suppresses sperm production
  • Annual implant
Efficacy trials of MENT implant under way; long-term toxicology testing not yet conducted.
Testosterone buciclate (TB)
  • Suppresses GnRH secretion and thus sperm production
  • Three-month injection
TB injectable tested in a WHO-supported study indicates stronger dosage necessary for reliable contraception. Trials of TB injectable and progestogen may begin in 1998.
Testosterone undecanoate (TU)
  • Suppresses GnRH secretion and thus sperm production
  • One or two-month injection
Studies among men under way in China of TU injectable; studies of two-month TU injection with a progestogen planned.
Testosterone enanthate (TE)
  • Suppresses GnRH secretion and thus sperm production
  • Weekly injection
Provided effective contraception in 98 percent of 399 men in a two-year WHO trial, but not considered desirable for general use because weekly injections are required.
TE/progestogen combination
  • Suppresses GnRH secretion and thus sperm production
  • Weekly injection of TE, daily progestogen pill
Combination of TE and progestogen achieved initial contraception sooner than TE alone, but not considered desirable for general use because weekly injections are required.
Non-hormonal Suppression of Sperm Production
Gossypol
  • Suppresses sperm production
  • Daily pill
  • Irreversible in some men
Recent pilot study of low-dose gossypol pill indicates effective contraception without dangerous potassium depletion. Larger efficacy study of 320 men planned.
Inhibition of Fertilizing Ability of Sperm
Nifedipine
  • May prevent sperm enzyme action needed for fertilization
  • Daily pill
Research planned to find variations of this drug that may specifically target sperm without producing systemic side effects.
Mifepristone (RU 486)
  • Makes sperm temporarily immotile
  • Daily pill
Research is seeking chemically-similar compounds that may target sperm without producing mifepristone's undesirable side effects.
Sperm surface protein
  • Antibodies attached to sperm block fertilization
  • Vaccine
Immunization of male guinea pigs with sperm surface protein has demonstrated reversible contraception. Other animal studies planned.

For more information, visit Family Health International's Website at www.fhi.org

Go to FHI's Network


| Home | Family Planning | Maternal & Neonatal Health | Cervical CancerRelated Health Topics
Tools for Trainers
| Reading Room | Related Links | Search ReproLine | Website Tools

Quick Search 

Website design copyright © 1995-2003 by JHPIEGO Corporation. All rights reserved.

Last Updated: 09 Jul 2003

URL: http://www.reproline.jhu.edu/
Reproductive Health Online (ReproLine): a family planning and reproductive health training website